Brief review of the role of glycogen synthase kinase-3β in amyotrophic lateral sclerosis

Neurology Research International

Volumn 2011, Issue , 2011, Pages

  Koh, Seong Ho ^a   Baek, Wonki ^a   Kim, Seung H ^a  

^a Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80051718959     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2011/205761     Document Type: Review

References (49)

1. A. Al-Chalabi and P. N. Leigh, "Recent advances in amyotrophic lateral sclerosis," Current Opinion in Neurology, vol. 13, no. 4, pp. 397-405, 2000.
2. J. S. Henkel, J. I. Engelhardt, L. Siklós et al., "Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue," Annals of Neurology, vol. 55, no. 2, pp. 221-235, 2004. (Pubitemid 38166999)
3. S. H. Kim, J. S. Henkel, D. R. Beers et al., "PARP expression is increased in astrocytes but decreased in motor neurons in the spinal cord of sporadic ALS patients," Journal of Neuropathology and Experimental Neurology, vol. 62, no. 1, pp. 88-103, 2003. (Pubitemid 36068896)
4. J. M. McCord and M. E. Gurney, "Mutant mice, CuZn superoxide dismutase, and motor neuron degeneration," Science, vol. 266, no. 5190, pp. 1586-1587, 1994.
5. W. Robberecht, "Oxidative stress in amyotrophic lateral sclerosis," Journal of Neurology, vol. 247, no. 1, pp. 1-6, 2000. (Pubitemid 30182081)
6. D. R. Rosen, T. Siddique, D. Patterson et al., "Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis," Nature, vol. 362, no. 6415, pp. 59-62, 1993. (Pubitemid 23087289)
7. M. Son, C. D. Cloyd, J. D. Rothstein, B. Rajendran, and J. L. Elliott, "Aggregate formation in Cu,Zn superoxide dismutaserelated proteins," Journal of Biological Chemistry, vol. 278, no. 16, pp. 14331-14336, 2003. (Pubitemid 36799983)
8. R.W. Strange, S. Antonyuk, M. A. Hough et al., "The structure of holo andmetal-deficient wild-type human Cu, Zn superoxide dismutase and its relevance to familial amyotrophic lateral sclerosis," Journal ofMolecular Biology, vol. 328, no. 4, pp. 877-891, 2003. (Pubitemid 36506893)
9. N. Embi, D. B. Rylatt, and P. Cohen, "Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase," European Journal of Biochemistry, vol. 107, no. 2, pp. 519-527, 1980.
10. R. S. Jope and G. V. W. Johnson, "The glamour and gloom of glycogen synthase kinase-3," Trends in Biochemical Sciences, vol. 29, no. 2, pp. 95-102, 2004. (Pubitemid 38186580)
11. J. R. Woodgett, "cDNA cloning and properties of glycogen synthase kinase-3," Methods in Enzymology, vol. 200, pp. 564-577, 1991.
12. G. Chen, K. A. Bower, C. Ma, S. Fang, C. J. Thiele, and J. Luo, "Glycogen synthase kinase 3? (GSK3?) mediates 6-hydroxydopamine-induced neuronal death," FASEB Journal, vol. 18, no. 10, pp. 1162-1164, 2004. (Pubitemid 39561557)
13. J. H. Hu, H. Zhang, R. Wagey, C. Krieger, and S. L. Pelech, "Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord," Journal of Neurochemistry, vol. 85, no. 2, pp. 432-442, 2003. (Pubitemid 36438338)
14. E. H. Koo and R. Kopan, "Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration," Nature Medicine, vol. 10, pp. S26-S33, 2004. (Pubitemid 38901864)
15. S. H. Koh, Y. B. Lee, K. S. Kim et al., "Role of GSK-3? activity inmotor neuronal cell death induced by G93A or A4V mutant hSOD1 gene," European Journal of Neuroscience, vol. 22, no. 2, pp. 301-309, 2005. (Pubitemid 41097603)
16. P. Watcharasit, G. N. Bijur, L. Song, J. Zhu, X. Chen, and R. S. Jope, "Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53," Journal of Biological Chemistry, vol. 278, no. 49, pp. 48872-48879, 2003.
17. G. N. Bijur and R. S. Jope, "Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3? in the regulation of HSF-1 activity," Journal of Neurochemistry, vol. 75, no. 6, pp. 2401-2408, 2000.
18. G. N. Bijur and R. S. Jope, "Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3?," Journal of Biological Chemistry, vol. 276, no. 40, pp. 37436-37442, 2001.
19. C. A. Grimes and R. S. Jope, "The multifaceted roles of glycogen synthase kinase 3? in cellular signaling," Progress in Neurobiology, vol. 65, no. 4, pp. 391-426, 2001. (Pubitemid 32781670)
20. T. Takadera and T. Ohyashiki, "Glycogen synthase kinase-3 inhibitors prevent caspase-dependent apoptosis induced by ethanol in cultured rat cortical neurons," European Journal of Pharmacology, vol. 499, no. 3, pp. 239-245, 2004. (Pubitemid 39233662)
21. M. Pap and G. M. Cooper, "Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway," Journal of Biological Chemistry, vol. 273, no. 32, pp. 19929-19932, 1998. (Pubitemid 28377539)
22. M. Pap andG. M. Cooper, "Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3? signaling pathway," Molecular and Cellular Biology, vol. 22, no. 2, pp. 578-586, 2002.
23. L. C. Cantley, "The phosphoinositide 3-kinase pathway," Science, vol. 296, no. 5573, pp. 1655-1657, 2002. (Pubitemid 34579158)
24. T. C. Dale, "Signal transduction by theWnt family of ligands," Biochemical Journal, vol. 329, no. 2, pp. 209-223, 1998. (Pubitemid 28040782)
25. J. Huelsken and J. Behrens, "The Wnt signalling pathway," Journal of Cell Science, vol. 115, no. 21, pp. 3977-3978, 2002. (Pubitemid 35446796)
26. B. A. Hemmings, D. Yellowlees, J. C. Kernohan, and P. Cohen, "Purification of glycogen synthase kinase 3 from rabbit skeletal muscle. Copurification with the activating factor (FA) of the (Mg-ATP) dependent protein phosphatase," European Journal of Biochemistry, vol. 119, no. 3, pp. 443-451, 1981.
27. F. Kirschenbaum, S. C. Hsu, B. Cordell, and J. V. McCarthy, "Glycogen synthase kinase-3? regulates presenilin 1 Cterminal fragment levels," Journal of Biological Chemistry, vol. 276, no. 33, pp. 30701-30707, 2001.
28. C. J. Phiel, C. A. Wilson, V. M. Y. Lee, and P. S. Klein, "GSK-3? regulates production of Alzheimer's disease amyloid-? peptides," Nature, vol. 423, no. 6938, pp. 435-439, 2003. (Pubitemid 36626994)
29. H. Decker, K. Y. Lo, S. M. Unger, S. T. Ferreira, and M. A. Silverman, "Amyloid-? peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3? in primary cultured hippocampal neurons," Journal of Neuroscience, vol. 30, no. 27, pp. 9166-9171, 2010.
30. T. Duka, M. Rusnak, R. E. Drolet et al., "Alpha-synuclein induces hyperphosphorylation of Tauin the MPTP model of Parkinsonism," FASEB Journal, vol. 20, no. 13, pp. 2302-2312, 2006. (Pubitemid 44953860)
31. H. Endo, C. Nito, H. Kamada, T. Nishi, and P. H. Chan, "Activation of the Akt/GSK3? signaling pathway mediates survival of vulnerable hippocampal neurons after transient global cerebral ischemia in rats," Journal of Cerebral Blood Flow and Metabolism, vol. 26, no. 12, pp. 1479-1489, 2006. (Pubitemid 44809077)
32. S. H. Koh, A. R. Yoo, D. I. Chang, S. J. Hwang, and S. H. Kim, "Inhibition of GSK-3 reduces infarct volume and improves neurobehavioral functions," Biochemical and Biophysical Research Communications, vol. 371, no. 4, pp. 894-899, 2008.
33. S. Guo, K. Arai, M. F. Stins, D. M. Chuang, and E. H. Lo, "Lithium upregulates vascular endothelial growth factor in brain endothelial cells and astrocytes," Stroke, vol. 40, no. 2, pp. 652-655, 2009.
34. A. B.Gold, N. Herrmann, and K. L. Lanct ot, "Lithium and its neuroprotective and neurotrophic effects: potential treatment for post-ischemic stroke sequelae," Current Drug Targets, vol. 12, no. 2, pp. 243-255, 2011.
35. W. Yang, C. Leystra-Lantz, and M. J. Strong, "Upregulation of GSK3? expression in frontal and temporal cortex in ALS with cognitive impairment (ALSci)," Brain Research, vol. 1196, pp. 131-139, 2008.
36. F. Sugai, Y. Yamamoto, K.Miyaguchi et al., "Benefit of valproic acid in suppressing disease progression of ALS model mice," European Journal of Neuroscience, vol. 20, no. 11, pp. 3179-3183, 2004. (Pubitemid 40007312)
37. H. L. Feng, Y. Leng, C. H. Ma, J. Zhang, M. Ren, and D. M. Chuang, "Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model," Neuroscience, vol. 155, no. 3, pp. 567-572, 2008.
38. S. H. Koh, Y. Kim, H. Y. Kim, S. Hwang, C. H. Lee, and S. H. Kim, "Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression ofG93A-SOD1 mousemodel of ALS," Experimental Neurology, vol. 205, no. 2, pp. 336-346, 2007. (Pubitemid 46755762)
39. S. H. Koh, H. Kwon, K. S. Kim et al., "Epigallocatechin gallate prevents oxidative-stress-induced death of mutant Cu/Znsuperoxide dismutase (G93A) motoneuron cells by alteration of cell survival and death signals," Toxicology, vol. 202, no. 3, pp. 213-225, 2004. (Pubitemid 39165396)
40. J. Calderó, N. Brunet, O. Tarabal et al., "Lithium prevents excitotoxic cell death of motoneurons in organotypic slice cultures of spinal cord," Neuroscience, vol. 165, no. 4, pp. 1353-1369, 2010.
41. S. H. Koh, S. H. Kim, H. Kwon et al., "Phosphatidylinositol-3 kinase/Akt and GSK-3 mediated cytoprotective effect of epigallocatechin gallate on oxidative stress-injured neuronaldifferentiated N18D3 cells," NeuroToxicology, vol. 25,no. 5, pp. 793-802, 2004. (Pubitemid 39013328)
42. H. Warita, Y. Manabe, T. Murakami, Y. Shiro, I. Nagano, and K. Abe, "Early decrease of survival signal-related proteins in spinal motor neurons of presymptomatic transgenic mice with a mutant SOD1 gene," Apoptosis, vol. 6, no. 5, pp. 345-352, 2001. (Pubitemid 32910875)
43. I. Nagano, T. Murakami, Y. Manabe, and K. Abe, "Early decrease of survival factors and DNA repair enzyme in spinal motor neurons of presymptomatic transgenic mice that express a mutant SOD1 gene," Life Sciences, vol. 72, no. 4-5, pp. 541-548, 2002. (Pubitemid 35447773)
44. B. Li, W. Xu, C. Luo, D. Gozal, and R. Liu, "VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death," Molecular Brain Research, vol. 111, no. 1-2, pp. 155-164, 2003. (Pubitemid 36332339)
45. L. Tolosa, M. Mir, V. J. Asensio, G. Olmos, and J. Lladó, "Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase," Journal of Neurochemistry, vol. 105, no. 4, pp. 1080-1090, 2008. (Pubitemid 351590778)
46. L. Tolosa, M. Mir, G. Olmos, and J. Lladó, "Vascular endothelial growth factor protects motoneurons from serum deprivation-induced cell death through phosphatidylinositol 3-kinase-mediated p38 mitogen-activated protein kinase inhibition," Neuroscience, vol. 158, no. 4, pp. 1348-1355, 2009.
47. M. Peviani, C. Cheroni, F. Troglio, M. Quarto, G. Pelicci, and C. Bendotti, "Lack of changes in the PI3K/AKT survival pathway in the spinal cordmotor neurons of amousemodel of familial amyotrophic lateral sclerosis," Molecular and Cellular Neuroscience, vol. 34, no. 4, pp. 592-602, 2007. (Pubitemid 46483084)
48. L. Meijer, M. Flajolet, and P. Greengard, "Pharmacological inhibitors of glycogen synthase kinase 3," Trends in Pharmacological Sciences, vol. 25, no. 9, pp. 471-480, 2004. (Pubitemid 39149703)
49. K. Y. Lee, S. H. Koh, M. Y. Noh, K. W. Park, Y. J. Lee, and S. H. Kim, "Glycogen synthase kinase-3? activity plays very important roles in determining the fate of oxidative stressinflicted neuronal cells," Brain Research, vol. 1129, no. 1, pp. 89-99, 2007. (Pubitemid 46048775)